FAQ

AGM 1883

Known as: AGM-1883 
 

Topic mentions per year

Topic mentions per year

1994-1999
01219941999

Related topics

Related topics

2 relations

Broader (2)

AcetamidesSpiro Compounds

Related mentions per year

Related mentions per year

1963-2018
1960198020002020
AGM 1883
Spiro Compounds
Acetamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.
A Phase I study of angiogenesis inhibitor TNP-470 was conducted in patients with advanced cancer. TNP-470 (25-235 mg/m2) was… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1999
1999
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor
SummaryProstate-specific antigen, PSA, is regarded as a reliable surrogate marker for androgen-independent prostate cancer (AIPC… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Quantitation of TNP-470 and its metabolites in human plasma: sample handling, assay performance and stability.
A selective and sensitive assay for the determination of TNP-470 and two of its metabolites, AGM-1883 and M-II, in human plasma… (More)
Is this relevant?
1997
1997
The pharmacokinetics of TNP-470, a new angiogenesis inhibitor.
STUDY OBJECTIVE To characterize the pharmacokinetic profile of TNP-470, a synthetic analog of fumagillin that is a potent… (More)
Is this relevant?
1994
1994
Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasma.
This paper describes a reversed-phase, high-performance liquid chromatographic (HPLC) method for the isolation, detection, and… (More)
Is this relevant?